Alembic Pharmaceuticals joint venture received USFDA approval for Diclofenac Sodium Topical Solution

Alembic Pharmaceuticals’s joint venture, Aleor Dermaceuticals Limited, has received US Food and Drug Administration (USFDA) Tentative Approval for Diclofenac Sodium Topical Solution USP, 2% w/w.

source https://www.pharmatutor.org/pharma-news/2019/alembic-pharmaceuticals-joint-venture-received-usfda-approval-for-diclofenac-sodium-topical-solution